Diagnostics ecosystem co-developer
As a diagnostics ecosystem co-developer, we adhere to the spirit of being open and collaborative, and strive to build an efficient, inclusive and sustainable diagnostics ecosystem. Our total solutions include open-system instruments, reagent services and core raw materials. We are dedicated to integrating upstream and downstream resources, accelerating the conversion from innovation to application, and introducing groundbreaking diagnostics solutions to global healthcare. To date, we have installed over 7,500 open-system instruments. Together with over 250 global ecosystem partners, we have made the industry a more open and inclusive arena for resource-sharing.
Comprehensive layout for industrial upgrading
As a key domestic supplier with one of the most comprehensive portfolios of diagnostics raw materials, we provide high-quality raw materials covering a range of morbidities and methodologies to help our customers increase their competitiveness and enrich product lines.
Our instruments, which span chemiluminescence immunoassay (CLIA), ultra-fast PCR, fluorescence-based lateral flow immunoassay and high-throughput sequencing, are efficient, universally adaptable, stable and open, helping customers reduce expenditure and development costs and accelerate product launch.
Our novel biomarker discovery and validation logic are empowered by advanced multi-omics and AI algorithms. Additionally, our novel macromolecule design and targeted evolution platform can help our customers achieve First-in-Class, Best-in-Class in their respective fields.
Open collaboration for mutual benefit
Our fundamental technologies are open to partners. Our total solutions cover novel biomarker discovery, open-system instruments and omni-dimensional market support, which work together to establish an IVD platform-based ecosystem where upstream, midstream and downstream partners can enjoy mutual benefits via strategic collaborations.
Customized services for addressing needs
We are customer-centric. As such, our comprehensive and customized services are dedicated to building an open, synergistic, win-win ecosystem that aids our partners in stacking up against competition.
-
For developers/R&D institutions
-
For manufacturers
-
For distributors
-
-
Innovative incubation platform
We establish dedicated disease-specific research and incubation platforms to foster innovation from inception to completion. Our bidirectional approach to innovative projects offers insights into clinical and commercial needs, supports cutting-edge detection platforms, and leverages AI-driven multi-omics biomarker discovery tools. This comprehensive ecosystem creates a multifaceted, differentiated approach that accelerates the translation of research findings into practical applications.
-
Industrial chain synergy
Our industrial chain (industrial capacity, global business channels), resource chain (big database, special disease big data, clinical research), and capital chain contribute to translating innovation into practical applications.
-
Business closed-loop support
A business closed-loop of research–independent clinical laboratory–clinical applications is built to support technical innovation and application development, translate scientific research into results, and deliver technical breakthroughs and clinical applications.
-
-
-
Open-system instruments
We provide various open and universal instruments to boost your reagent development and innovation.
-
High-performance product support
Our high-quality raw materials and reagent services cover multiple morbidities and methodologies, including infectious diseases, tumors, cardiac diseases, inflammation and neurological disorders, and facilitate your developing and launching new products.
-
Technical and after-sales support
Our comprehensive technical support, services and after-sales support serve to promote product development and help you expand your market.
-
-
-
Enterprise transformation
Our open-system instruments and reagent services can help you transition from being distributors to platform operators, and further to brand holders.
-
Market support
Our market analysis and marketing strategy support can help you stand head and shoulders above the field.
-
After-sales support
We identify and resolve product and operation problems efficiently, thereby improving the overall satisfaction of end users.
-
Partnerships for a shared future
We have an extensive history of driving innovation in the IVD industry through close collaboration with many well-known companies in China and abroad. We look forward to working together with more and new partners for the promising future of the IVD industry.
-
7500+
open-system instruments installed
-
250+
global ecosystem partners
-
200+
collaboration projects
-
Collaboration with CR Pharma Comm Medical Devices
CR Pharma Comm Medical Devices’ national distributor network and resources in healthcare facilities were leveraged to build an IVD open platform-based ecosystem.
-
Strategic collaboration with Roche Diagnostics
In-depth collaboration in technologies and services of raw materials and molecular diagnostics was carried out to jointly develop and optimize solutions to address local needs.
-
Collaboration with Halodoc Indonesia
We are promoting IVD technologies and IVD localization in Indonesia through a partnership with the largest telehealth platform in the country.
-
Collaboration with Kalbe Farma Indonesia
In-depth collaboration with the one of the biggest public pharmaceutical company in Southeast Asia has contributed to the localization of IVD in Indonesia.
-
We are delighted to strike strategic partnership with Fapon Biotech, a leading upstream company in the China IVD industry, in building an innovative ecosystem. Jointly, we are now at the starting point of introducing innovative solutions and technologies of precision medicine into the China market.
Roche Diagnostics -
Fapon is adept at developing raw materials, and has built a robust portfolio of quality products in a variety of categories. The company also provides open-system instruments for CLIA and POCT molecular diagnostics. We believe Fapon is the partner of choice for us in China.
CR Pharma Comm Medical Devices -
We are delighted to join hands with Fapon in a strategic partnership that combines our commitment to innovation with Fapon’s expertise in IVD technologies to answer the need for advanced diagnostics and healthcare services.
Halodoc, Indonesia
Join us for a better future of IVD.
If you have any question or need any support, please fill out the information below.